IL122802A0 - Gene preparations - Google Patents

Gene preparations

Info

Publication number
IL122802A0
IL122802A0 IL12280296A IL12280296A IL122802A0 IL 122802 A0 IL122802 A0 IL 122802A0 IL 12280296 A IL12280296 A IL 12280296A IL 12280296 A IL12280296 A IL 12280296A IL 122802 A0 IL122802 A0 IL 122802A0
Authority
IL
Israel
Prior art keywords
gene preparations
preparations
gene
desired genes
carriers
Prior art date
Application number
IL12280296A
Other languages
English (en)
Original Assignee
Koken Kk
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Kk, Sumitomo Pharma filed Critical Koken Kk
Publication of IL122802A0 publication Critical patent/IL122802A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12280296A 1995-07-03 1996-07-02 Gene preparations IL122802A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16774495 1995-07-03
PCT/JP1996/001824 WO1997002047A1 (fr) 1995-07-03 1996-07-02 Preparations de genes

Publications (1)

Publication Number Publication Date
IL122802A0 true IL122802A0 (en) 1998-08-16

Family

ID=15855313

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12280296A IL122802A0 (en) 1995-07-03 1996-07-02 Gene preparations
IL122802A IL122802A (en) 1995-07-03 1997-06-20 Continuous release of a genetic preparation in the form of a gel

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL122802A IL122802A (en) 1995-07-03 1997-06-20 Continuous release of a genetic preparation in the form of a gel

Country Status (12)

Country Link
EP (1) EP0844004B1 (zh)
KR (1) KR100431779B1 (zh)
CN (1) CN1230205C (zh)
AT (1) ATE372787T1 (zh)
AU (1) AU704694B2 (zh)
CA (1) CA2225998C (zh)
DE (1) DE69637243T2 (zh)
ES (1) ES2293648T3 (zh)
IL (2) IL122802A0 (zh)
NZ (1) NZ311175A (zh)
TW (1) TW577747B (zh)
WO (1) WO1997002047A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543994B1 (ko) * 1996-04-12 2006-10-31 더 리젠츠 오브 더 유니버시티 오브 미시건 상처치료를위한invivo유전자전달방법
EP1078639A4 (en) * 1998-05-22 2004-10-06 Sumitomo Pharma STABLE GENERATION
KR100608154B1 (ko) 1998-07-01 2006-08-04 다카라 바이오 가부시키가이샤 유전자 도입 방법
JP5118285B2 (ja) * 2000-06-20 2013-01-16 大日本住友製薬株式会社 オリゴヌクレオチド導入製剤
BR0209046A (pt) * 2001-04-20 2004-11-09 Alza Corp Disposição de microprojeção que possui um agente benéfico contendo revestimento
EP1752189A3 (en) * 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
DK1407787T3 (da) * 2001-06-20 2009-06-02 Dainippon Sumitomo Pharma Co Fremgangsmåde til fremme af nukleinsyreoverförsel
WO2003070256A1 (en) * 2002-02-15 2003-08-28 Research Development Foundation Hyaluronic acid mediated adenoviral transduction
WO2005077333A2 (en) * 2004-02-10 2005-08-25 University Of Florida Research Foundation, Inc. Gel-based delivery of recombinant adeno-associated virus vectors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
JPS60126217A (ja) * 1983-12-14 1985-07-05 Sumitomo Chem Co Ltd 長期徐放性製剤
JPH0759522B2 (ja) * 1985-12-27 1995-06-28 住友製薬株式会社 徐放性製剤の製造法
DE3802158A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Vorrichtung zur applikation von implantaten
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤
JP2789115B2 (ja) * 1989-09-07 1998-08-20 株式会社高研 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法
CA2109955A1 (en) * 1991-05-24 1992-11-26 Toru Hayakawa Equipment for intracerebral administration of preparations
CA2160877A1 (en) * 1993-04-19 1994-10-27 Michael David Amos Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
AU710504B2 (en) * 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system

Also Published As

Publication number Publication date
EP0844004A1 (en) 1998-05-27
IL122802A (en) 2007-09-20
WO1997002047A1 (fr) 1997-01-23
AU704694B2 (en) 1999-04-29
AU6243696A (en) 1997-02-05
CN1230205C (zh) 2005-12-07
DE69637243D1 (de) 2007-10-25
CA2225998C (en) 2010-11-02
TW577747B (en) 2004-03-01
CN1193916A (zh) 1998-09-23
DE69637243T2 (de) 2008-06-19
KR19990028522A (ko) 1999-04-15
ES2293648T3 (es) 2008-03-16
KR100431779B1 (ko) 2004-09-04
EP0844004A4 (en) 2000-03-15
NZ311175A (en) 1999-11-29
EP0844004B1 (en) 2007-09-12
CA2225998A1 (en) 1997-01-23
ATE372787T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
AU699706C (en) Improved vectors for gene therapy
EP0625049A4 (en) EX VIVO GENTRANSFER.
KR100253672B1 (en) Methods and applications for efficient genetic suppressor elements
AU6617898A (en) An antisense oligonucleotide preparation method
EP0633943A4 (en) GENTHERAPY USING TARGETED VIRAL VECTORS.
ES2085966T3 (es) Mecanismos geneticos de supresion de tumores.
EP0773296A4 (en) SECRETION SIGNAL GENE AND EXPRESSION VECTOR COMPRISING THIS SIGNAL
EP0722342A4 (en) REGULATION OF GENE EXPRESSION OF bcl-2
IL122802A0 (en) Gene preparations
EP0657512A3 (en) Silicone containing artists' media
GB9306386D0 (en) Gene expression
IL117713A0 (en) Gene expression system
AU5315796A (en) Mammalian expression vectors
AUPN631495A0 (en) Vaccine and biological vector(I)
AU5590394A (en) Transglutaminase gene
AUPN631395A0 (en) Vaccine and biological vector(II)
AU5703796A (en) Improved retroviral vectors, especially suitable for gene th erapy
IL120076A (en) Substantially pure dna sequence containing the dysautonomia gene
AU4839493A (en) Portable intron as an insertion vector for gene insertion
ZA942685B (en) Genetic stabilizing elements
AU4941096A (en) Self-deleting vectors for gene therapy
EP0658196A4 (en) GENE INSERTION BY DIRECT -i (IN VITRO) LINK.
GB9607700D0 (en) Gene promoter sequence from banana
AU3036197A (en) Adenovirus vectors for gene therapy
GB9505892D0 (en) Vectors for gene delivery

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed